Bibliography

Anita T. Shaffer. Macrophage CAR Therapies Show Early Signals of Activity against Solid Tumors. SITC 31st Annual Meeting and Associated Programs DAILY, p.8, Nov 2016. 

Sotillo Elena, Barrett David M, Black Kathryn L, Bagashev Asen, Oldridge Derek, Wu Glendon, Sussman Robyn, Lanauze Claudia, Ruella Marco, Gazzara Matthew R, Martinez Nicole M, Harrington Colleen T, Chung Elaine Y, Perazzelli Jessica, Hofmann Ted J, Maude Shannon L, Raman Pichai, Barrera Alejandro, Gill Saar, Lacey Simon F, Melenhorst Jan J, Allman David, Jacoby Elad, Fry Terry, Mackall Crystal, Barash Yoseph, Lynch Kristen W, Maris John M, Grupp Stephan A, Thomas-Tikhonenko Andrei: Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy. Cancer discovery 5(12): 1282-95, Dec 2015.

Gill Saar, Maus Marcela V, Porter David L: Chimeric antigen receptor T cell therapy: 25years in the making. Blood reviews Nov 2015.

Reshef Ran, Huffman Austin P, Gao Amy, Luskin Marlise R, Frey Noelle V, Gill Saar I, Hexner Elizabeth O, Kambayashi Taku, Loren Alison W, Luger Selina M, Mangan James K, Nasta Sunita D, Richman Lee P, Sell Mary, Stadtmauer Edward A, Vonderheide Robert H, Mick Rosemarie, Porter David L: High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33(21): 2392-8, Jun 2015.

Ruella Marco, Gill Saar: How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia. Expert opinion on biological therapy 15(6): 761-6, Jun 2015.

Gill Saar: The Yin and Yang of Alloreactivity: Chronic Graft-versus-Host Disease and Leukemia Relapse. Clinical cancer research : an official journal of the American Association for Cancer Research 21(9): 1981-3, May 2015.

Bagley Stephen J, Sehgal Alison R, Gill Saar, Frey Noelle V, Hexner Elizabeth O, Loren Alison W, Mangan James K, Porter David L, Stadtmauer Edward A, Reshef Ran, Luger Selina M: Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 21(4): 768-71, Apr 2015.

Gill Saar, June Carl H: Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunological reviews 263(1): 68-89, Jan 2015.

Reshef Ran, Hexner Elizabeth O, Loren Alison W, Frey Noelle V, Stadtmauer Edward A, Luger Selina M, Mangan James K, Gill Saar I, Vassilev Pavel, Lafferty Kathryn A, Smith Jacqueline, Van Deerlin Vivianna M, Mick Rosemarie, Porter David L: Early donor chimerism levels predict relapse and survival after allogeneic stem-cell transplantation with reduced intensity conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jul 2014.

Gill Saar, Tasian Sarah K, Ruella Marco, Shestova Olga, Li Yong, Porter David L, Carroll Martin, Danet-Desnoyers Gwenn, Scholler John, Grupp Stephan A, June Carl H, Kalos Michael: Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. Blood 123(15): 2343-54, Apr 2014.

Gill Saar, Porter David L: CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road. Expert opinion on biological therapy 14(1): 37-49, Jan 2014.